UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Autosomal dominant cerebellar ataxias: a systematic review of clinical features

European journal of neurology, 2014-04, Vol.21 (4), p.607-615

2014

Volltextzugriff (PDF)

Sensory abnormalities and pain in Parkinson disease and its modulation by treatment of motor symptoms

European journal of pain, 2016-02, Vol.20 (2), p.151-165

2016

Volltextzugriff (PDF)

Apomorphine for the treatment of refractory motor fluctuations in late stage Parkinson's disease: an old drug revisited

European journal of neurology, 2013-11, Vol.20 (11), p.1427-1428

Perez-Lloret, S.

2013

Volltextzugriff (PDF)

Oro-buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson's disease: preliminary analysis from the French COPARK cohort

European journal of neurology, 2012-01, Vol.19 (1), p.28-37

2012

Volltextzugriff (PDF)

Decision-making in Parkinson's disease patients with and without pathological gambling

European journal of neurology, 2010-01, Vol.17 (1), p.97-102

2010

Volltextzugriff (PDF)

Predictors of Cardiovascular Autonomic Neuropathy Onset and Progression in a Cohort of Type 1 Diabetic Patients

Journal of Diabetes Research, 2018-01, Vol.2018 (2018), p.1-8

2018

Volltextzugriff (PDF)

New insights into orthostatic hypotension in multiple system atrophy: a European multicentre cohort study

Journal of neurology, neurosurgery and psychiatry, 2016-05, Vol.87 (5), p.554-561

2016

Volltextzugriff (PDF)

The new Parkinson's disease pain classification system (PD-PCS)

Nervenarzt, 2022-10, Vol.93 (10), p.1019-1027

2022

Volltextzugriff (PDF)

Dyskinesias induced by subthalamotomy in Parkinson’s disease are unresponsive to amantadine

Journal of neurology, neurosurgery and psychiatry, 2006-02, Vol.77 (2), p.172-174

2006

Volltextzugriff (PDF)

Adverse drug reactions with Selegiline and Rasagiline compared to Levodopa and Ropinirole: A study in the French Pharmacovigilance Database

Journal of the neurological sciences, 2013-10, Vol.333, p.e129-e129

2013

Volltextzugriff (PDF)

Risk of Cardiovascular events Associated with Necessary Interventions for Parkinson Disease

Value in health, 2015-05, Vol.18 (3), p.A278-A278

2015

Volltextzugriff (PDF)

Autosomal dominant cerebellar ataxias: A systematic review of clinical features

Journal of the neurological sciences, 2013-10, Vol.333, p.e610-e610

2013

Volltextzugriff (PDF)

Prospective randomized 1-year follow-up comparison of bilateral subthalamotomy versus bilateral subthalamic stimulation and the combination of both in Parkinson's disease patients: a pilot study

British journal of neurosurgery, 2008-06, Vol.22 (3), p.415-422

2008

Volltextzugriff (PDF)

Pregabalin beneficial effects on sleep quality or health-related quality of life are poorly correlated with reduction on pain intensity after an 8-week treatment course

Clinical neuropharmacology, 2012-01, Vol.35 (1), p.21-24

2012

Volltextzugriff (PDF)

2.279 ADVERSE EVENTS TO ANTIPARKINSONIAN MEDICATIONS IN PARKINSONIAN AND NON-PARKINSONIAN PATIENTS

Parkinsonism & related disorders, 2012, Vol.18, p.S135-S135

2012

Volltextzugriff (PDF)

2.282 FACTORS RELATED TO ORTHOSTATIC HYPOTENSION IN PARKINSON'S DISEASE

Parkinsonism & related disorders, 2012, Vol.18, p.S136-S136

2012

Volltextzugriff (PDF)

2.284 IMPULSE-CONTROL DISORDERS IN PARKINSON'S DISEASE PATIENTS

Parkinsonism & related disorders, 2012, Vol.18, p.S136-S136

2012

Volltextzugriff (PDF)

Neuroprotection: New Approaches and Prospects

2020

Volltextzugriff (PDF)

Role of Astrocytic Dysfunction in the Pathogenesis of Parkinson’s Disease Animal Models from a Molecular Signaling Perspective

Neural plasticity, 2020, Vol.2020 (2020), p.1-10

2020

Volltextzugriff (PDF)

Prevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease

Clinical neuropharmacology, 2012-11, Vol.35 (6), p.261-265

2012

Volltextzugriff (PDF)

Safety of rasagiline for the treatment of Parkinson's disease

Expert opinion on drug safety, 2011-07, Vol.10 (4), p.633-643

2011

Volltextzugriff (PDF)

Rotigotine transdermal delivery for the treatment of Parkinson's disease

Expert opinion on pharmacotherapy, 2009-03, Vol.10 (4), p.677-691

2009

Volltextzugriff (PDF)

P3.135 Predictive factors for PD progression – preliminary results of PARKMIP/COPARK cohort after 24-months follow up

Parkinsonism & related disorders, 2009, Vol.15, p.S182-S183

2009

Volltextzugriff (PDF)

Drugs associated with restless legs syndrome: a case/noncase study in the French Pharmacovigilance Database

Journal of clinical psychopharmacology, 2012-12, Vol.32 (6), p.824-827

2012

Volltextzugriff (PDF)

1 – 25 von 282

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(259)
Mit Volltextzugriff
(225)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Autosomal dominant cerebellar ataxias: a systematic review of clinical features

Sensory abnormalities and pain in Parkinson disease and its modulation by treatment of motor symptoms

Apomorphine for the treatment of refractory motor fluctuations in late stage Parkinson's disease: an old drug revisited

Oro-buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson's disease: preliminary analysis from the French COPARK cohort

Decision-making in Parkinson's disease patients with and without pathological gambling

Predictors of Cardiovascular Autonomic Neuropathy Onset and Progression in a Cohort of Type 1 Diabetic Patients

New insights into orthostatic hypotension in multiple system atrophy: a European multicentre cohort study

L‐DOPA‐induced dyskinesias, motor fluctuations and health‐related quality of life: the COPARK survey

The new Parkinson's disease pain classification system (PD-PCS)

Dyskinesias induced by subthalamotomy in Parkinson’s disease are unresponsive to amantadine

Adverse drug reactions with Selegiline and Rasagiline compared to Levodopa and Ropinirole: A study in the French Pharmacovigilance Database

Risk of Cardiovascular events Associated with Necessary Interventions for Parkinson Disease

Autosomal dominant cerebellar ataxias: A systematic review of clinical features

Prospective randomized 1-year follow-up comparison of bilateral subthalamotomy versus bilateral subthalamic stimulation and the combination of both in Parkinson's disease patients: a pilot study

Pregabalin beneficial effects on sleep quality or health-related quality of life are poorly correlated with reduction on pain intensity after an 8-week treatment course

2.279 ADVERSE EVENTS TO ANTIPARKINSONIAN MEDICATIONS IN PARKINSONIAN AND NON-PARKINSONIAN PATIENTS

2.282 FACTORS RELATED TO ORTHOSTATIC HYPOTENSION IN PARKINSON'S DISEASE

2.284 IMPULSE-CONTROL DISORDERS IN PARKINSON'S DISEASE PATIENTS

Neuroprotection: New Approaches and Prospects

Role of Astrocytic Dysfunction in the Pathogenesis of Parkinson’s Disease Animal Models from a Molecular Signaling Perspective

Prevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease

Safety of rasagiline for the treatment of Parkinson's disease

Rotigotine transdermal delivery for the treatment of Parkinson's disease

P3.135 Predictive factors for PD progression – preliminary results of PARKMIP/COPARK cohort after 24-months follow up

Drugs associated with restless legs syndrome: a case/noncase study in the French Pharmacovigilance Database

Suchergebnisse filtern